Politics

Politics By Nicholas Florko

Burr, in line to lead Senate Republicans’ health strategy, has a long history of antagonizing the FDA

Politics By Nicholas Florko

Which pricey drugs will Trump’s international pricing policy target?

Politics By Nicholas Florko and Lev Facher

Trump’s making last-minute drug pricing reforms — and surprisingly, Democrats want Biden to keep the biggest one

Politics By Lev Facher

Biden adviser says scientists, not political appointees, should lead public communications on Covid-19

Pharmalot By Ed Silverman

House passes a bill to close a loophole in a law that gives drug makers ‘unfair’ monopolies

Politics By Nicholas Florko

Biden team ramps up outreach to public health groups 

Politics By Andrew Joseph

California voters approve another round of funding for stem cell research

Politics By Lev Facher

With Ron Klain, Biden picks a pandemic-response veteran for chief of staff

Politics By Lev Facher

With Murthy, Nunez-Smith, and Kessler, Biden leans on experience to steer Covid-19 task force

Politics By Lev Facher

Biden promises to roll out a Covid-19 task force on Monday

Politics By Lev Facher

‘It’s going to be very, very scary’: Before Biden takes office, a precarious 10 weeks for escalating Covid-19 crisis

Politics By Lev Facher

Biden’s ready to start his pandemic response immediately 

Politics By Kate Sheridan

‘I don’t think it goes away’: Pharma experts weigh in on the next 4 years of drug pricing reform

Politics By Nicholas Florko

‘Science was on the ballot’: How can public health recover from a rebuke at the polls?

Politics By Andrew Joseph, Lev Facher, Kate Sheridan, and Nicholas Florko

Shalala loses — and other 2020 election results that will have big implications for health and science

Politics By Casey Ross, Usha Lee McFarling, Nicholas St. Fleur, and Becky Lang

Ubiquitous hand sanitizers and grousing about masks: Snapshots from around the nation of voting in a pandemic

Politics By Lev Facher, Nicholas Florko, Andrew Joseph, and Kate Sheridan

Doctors in Congress, new e-cigarette taxes, stem cells, and abortion rights: Here’s what STAT is watching tonight

Politics By Lev Facher

Trump threatens to fire Fauci ‘after the election’

A STAT Investigation By Kathleen McLaughlin

HHS relaxed oversight of problematic Covid-19 tests despite being told of accuracy concerns

Politics By Lev Facher

Will Fauci have a job? Will the public regain trust in the FDA? 8 of the scientific institutions and traditions on the line on Tuesday

Politics By Nicholas Florko and Kate Sheridan

Biden’s policies could spell trouble for biotech — but industry CEOs are backing him anyway

Politics By Lev Facher

Trump administration finalizes rule forcing insurers to disclose negotiated prices, including for drugs

Health By Andrew Joseph

Is it safe to lick the ballot envelope? Public health officials take on the new challenge of making voting safe amid a pandemic

Politics By Lev Facher

In a pivotal race in North Carolina, Democrats try to paint the incumbent as ‘pharma’s favorite senator’

Politics By Nicholas Florko

Amid Covid-19, tiny biotech companies are hiring lobbyists for the first time

Politics By Nicholas Florko

Quinn Nystrom is betting a platform laser-focused on high insulin prices will propel her to Congress

Politics By Usha Lee McFarling

With wildfires burning and Covid-19 spreading, can California afford stem cell research? Voters are set to decide

Don't Miss By STAT staff

As STAT turns 5, a look back at science and medicine’s biggest headlines and controversies

Politics By Lev Facher

As Trump misleadingly boasts of ‘rounding the turn’ on Covid-19, Biden warns of ‘dark winter’